If you're looking for stocks that can provide life-changing returns, the healthcare sector has exactly what want. Laboratory-to-market synthetic biology, or synbio, platforms are a dime a dozen these days, but Amyris stands head and shoulders above the rest. In March, Amyris announced success at producing a large quantity of cannabigerol (CBG), which is a naturally occurring cannabinoid many times more potent than cannabidiol (CBD).
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting